PHENYLEPHRINE HYDROCHLORIDE AND PROMETHAZINE HYDROCHLORIDE Drug Patent Profile
When do Phenylephrine Hydrochloride And Promethazine Hydrochloride patents expire, and what generic alternatives are available?
Phenylephrine Hydrochloride And Promethazine Hydrochloride is a drug marketed by Hikma and Pai Holdings and is included in two NDAs.
The generic ingredient in PHENYLEPHRINE HYDROCHLORIDE AND PROMETHAZINE HYDROCHLORIDE is phenylephrine hydrochloride; promethazine hydrochloride. There is one drug master file entry for this compound. Two suppliers are listed for this compound. Additional details are available on the phenylephrine hydrochloride; promethazine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Phenylephrine Hydrochloride And Promethazine Hydrochloride
A generic version of PHENYLEPHRINE HYDROCHLORIDE AND PROMETHAZINE HYDROCHLORIDE was approved as phenylephrine hydrochloride; promethazine hydrochloride by PAI HOLDINGS on December 7th, 2006.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for PHENYLEPHRINE HYDROCHLORIDE AND PROMETHAZINE HYDROCHLORIDE?
- What are the global sales for PHENYLEPHRINE HYDROCHLORIDE AND PROMETHAZINE HYDROCHLORIDE?
- What is Average Wholesale Price for PHENYLEPHRINE HYDROCHLORIDE AND PROMETHAZINE HYDROCHLORIDE?
Summary for PHENYLEPHRINE HYDROCHLORIDE AND PROMETHAZINE HYDROCHLORIDE
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 2 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 3 |
| Clinical Trials: | 1 |
| Patent Applications: | 2 |
| DailyMed Link: | PHENYLEPHRINE HYDROCHLORIDE AND PROMETHAZINE HYDROCHLORIDE at DailyMed |
Recent Clinical Trials for PHENYLEPHRINE HYDROCHLORIDE AND PROMETHAZINE HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| University of North Carolina, Chapel Hill | PHASE4 |
See all PHENYLEPHRINE HYDROCHLORIDE AND PROMETHAZINE HYDROCHLORIDE clinical trials
Pharmacology for PHENYLEPHRINE HYDROCHLORIDE AND PROMETHAZINE HYDROCHLORIDE
| Drug Class | Phenothiazine alpha-1 Adrenergic Agonist |
| Mechanism of Action | Adrenergic alpha1-Agonists |
US Patents and Regulatory Information for PHENYLEPHRINE HYDROCHLORIDE AND PROMETHAZINE HYDROCHLORIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hikma | PHENYLEPHRINE HYDROCHLORIDE AND PROMETHAZINE HYDROCHLORIDE | phenylephrine hydrochloride; promethazine hydrochloride | SYRUP;ORAL | 040675-001 | Dec 23, 2014 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Pai Holdings | PHENYLEPHRINE HYDROCHLORIDE AND PROMETHAZINE HYDROCHLORIDE | phenylephrine hydrochloride; promethazine hydrochloride | SYRUP;ORAL | 040654-001 | Dec 7, 2006 | AA | RX | No | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
